Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tongluo kaibi
- Development stage
- Phase 4
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongluo Kaibi is a traditional Chinese medicine tablet used primarily for the treatment of rheumatic and musculoskeletal disorders such as rheumatoid arthritis and knee osteoarthritis. It has been studied in combination with other therapies (e.g., etanercept or intra-articular injections) to improve clinical symptoms, relieve pain, reduce inflammatory markers (such as TNF-α and IL-1β), and enhance joint function. The exact mechanism of action is not fully elucidated in Western scientific literature but is believed to involve anti-inflammatory effects based on observed reductions in inflammatory cytokines.
- Brand names
- Tongluo Kaibi TabletTongluo-Kaibi Tablet
- Other names
- tongluokaibitong luo kai bi tablet通络开痹片
Beyond the preview
Go deeper on tongluo kaibi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tongluo kaibi.